Hoth Therapeutics Initiates Confirmatory Study for Lupus Treatment
Hoth Therapeutics, Inc….today announced initiating a confirmatory study, related to their proprietary AEA-loaded Z-pods in the treatment of Cutaneous Lupus Erythematosus [CLE], a chronic autoimmune disease that affects the skin. The study is being conducted in partnership with Zylo Therapeutics to confirm that topical administration of Hoth’s AEA-loaded Z-pods inhibits the development of CLE lesions in a well-established animal model of lupus. Read more >>